Mamedica Ltd
ASA upheld a complaint over a Mamedica medical cannabis clinic fee comparison
Not yet reviewed by our editors. This entry reports what the cited sources say; it may change as we check it. How we check
This entry is about the United Kingdom — not the country you picked in the header.
According to Advertising Standards Authority (UK), Jan 28, 2026 · Read the source
Summary
The ASA published a ruling on 28 January 2026 about the website of Mamedica Ltd, a medical cannabis clinic in London. The pricing page, seen in May 2025, said clinic fees drop to zero after the first year, "lower than any other clinic in the UK", and showed a bar chart of average year-two fees.
The ASA held that the comparison with named competitors was not verifiable: the page did not explain the method behind the "average year 2" figures, the features included for each provider, or the dates and sources of competitor prices. It found a breach of CAP Code rule 3.34 and told Mamedica not to make misleading price-advantage claims or leave the basis of comparisons unclear.
What the source found
- Ad: pricing page of mamedica.co.uk, seen May 2025.
- Finding: comparison with competitors not verifiable; basis not made clear.
- Rule breached: CAP Code 3.34.
Timeline
ASA ruling published (complaint upheld)
Sources
- Regulator
Advertising Standards Authority (UK) · Jan 28, 2026
ASA ruling on Mamedica Ltd
Wording on this page follows the sources. Found an error? See the corrections process in our editorial policy.
Status notes
[dataset] ASA rulings search (asa.org.uk/codes-and-rulings/rulings.html, terms cbd/cannabis), retrieved 2026-09-30
Comments
No comments yet.
Related entries
The full Red ListTell us what happened
Every report is read by a person. You don’t need to prove anything, and we never publish your name.
- A moderator reads your report and checks the link against the Red List and our seller records.
- We look for an authoritative source — a regulator, court, police or consumer-protection finding.
- When a source confirms it, your report is linked to a Red List entry. Your name and contact details stay private.